BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18652780)

  • 1. Rosiglitazone attenuates allergic inflammation and inhibits expression of galectin-3 in a mouse model of allergic rhinitis.
    Han JL; Ding RY; Zhao L; Ren Z; Jiang XJ
    J Int Med Res; 2008; 36(4):830-6. PubMed ID: 18652780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of peroxisome proliferator-activated receptor-gamma agonist on a murine model of experimental allergic rhinitis.
    Jeon EJ; Lee SK; Park YS; Kim DH; Yum JH; Park CS
    Otolaryngol Head Neck Surg; 2008 Jul; 139(1):124-30. PubMed ID: 18585574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma negatively regulates allergic rhinitis in mice.
    Fukui N; Honda K; Ito E; Ishikawa K
    Allergol Int; 2009 Jun; 58(2):247-53. PubMed ID: 19307774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma agonist induces regulatory T cells in a murine model of allergic rhinitis.
    Wang W; Zhu Z; Zhu B; Ma Z
    Otolaryngol Head Neck Surg; 2011 Apr; 144(4):506-13. PubMed ID: 21493225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of interleukin 17A to the development and regulation of allergic inflammation in a murine allergic rhinitis model.
    Quan SH; Zhang YL; Han DH; Iwakura Y; Rhee CS
    Ann Allergy Asthma Immunol; 2012 May; 108(5):342-50. PubMed ID: 22541406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone attenuates allergic inflammation and induces production of regulatory T lymphocytes.
    Wang W; Zhu Z; Zhu B; Ma Z
    Am J Rhinol Allergy; 2010; 24(6):454-8. PubMed ID: 21144225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and significance of galectin-3 and galectin-9 in mice nasal mucosa with allergic rhinitis].
    Han JL; Ren Z; Jiang XJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Jul; 43(7):504-8. PubMed ID: 18826117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, in a mouse allergic asthma model is not associated with the recruitment or generation of Foxp3-expressing CD4
    Maślanka T; Otrocka-Domagała I; Zuśka-Prot M; Gesek M
    Eur J Pharmacol; 2019 Apr; 848():30-38. PubMed ID: 30710547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
    Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
    Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation.
    Park SJ; Lee KS; Kim SR; Min KH; Choe YH; Moon H; Chae HJ; Yoo WH; Lee YC
    J Immunol; 2009 Sep; 183(5):3259-67. PubMed ID: 19641141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of peroxisome proliferator-activated receptor gamma in perennial allergic rhinitis.
    Kang HJ; Cinn YG; Hwang SJ; Won Chae S; Woo JS; Lee SH; Lee HM
    Arch Otolaryngol Head Neck Surg; 2006 Nov; 132(11):1196-200. PubMed ID: 17116814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-allergic function and regulatory mechanisms of KR62980 in allergen-induced airway inflammation.
    Won HY; Min HJ; Ahn JH; Yoo SE; Bae MA; Hong JH; Hwang ES
    Biochem Pharmacol; 2010 Mar; 79(6):888-96. PubMed ID: 19896472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 5-aminosalicylate on allergic rhinitis model in mice.
    Kuyama S; Yamamoto A; Sugiyama M; Kakuta H; Sugimoto Y
    Int Immunopharmacol; 2010 Jun; 10(6):713-6. PubMed ID: 20304104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism of Staphylococcus aureus colonization and allergic reaction in the nasal cavity in mice.
    Hohchi N; Hashida K; Ohkubo J; Wakasugi T; Mori T; Nguyen KH; Kuroda E; Ikeno T; Taniguchi H; Suzuki H
    Int Arch Allergy Immunol; 2012; 159(1):33-40. PubMed ID: 22555155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates airway inflammation by inhibiting the proliferation of effector T cells in a murine model of neutrophilic asthma.
    Zhao Y; Huang Y; He J; Li C; Deng W; Ran X; Wang D
    Immunol Lett; 2014; 157(1-2):9-15. PubMed ID: 24269293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical role of IL-33 in experimental allergic rhinitis.
    Haenuki Y; Matsushita K; Futatsugi-Yumikura S; Ishii KJ; Kawagoe T; Imoto Y; Fujieda S; Yasuda M; Hisa Y; Akira S; Nakanishi K; Yoshimoto T
    J Allergy Clin Immunol; 2012 Jul; 130(1):184-94.e11. PubMed ID: 22460070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant drug, desipramine, alleviates allergic rhinitis by regulating Treg and Th17 cells.
    Zhang Y; Zhen H; Yao W; Bian F; Mao X; Yang X; Jin S
    Int J Immunopathol Pharmacol; 2013; 26(1):107-15. PubMed ID: 23527713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiallergic Function of KR62980, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in a Mouse Allergic Rhinitis Model.
    Lee JE; Zhang YL; Han DH; Kim DY; Rhee CS
    Allergy Asthma Immunol Res; 2015 May; 7(3):256-64. PubMed ID: 25749778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vivo antioxidant and anti-inflammatory activity of rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonists in animal model of bronchial asthma.
    El-Naa MM; El-Refaei MF; Nasif WA; Abduljawad SH; El-Brairy AI; El-Readi MZ
    J Pharm Pharmacol; 2015 Oct; 67(10):1421-30. PubMed ID: 26099551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.